A selection of recent
publications from the
Samsara team
Publications
IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms (2021) Journal for Immunotherapy of Cancer
Digesting the crisis: autophagy and coronaviruses (2020) Microbial Cell
Importance of Quantifying Drug-Target Engagement in Cells (2020) ACS Med. Chem. Lett.
A discovery platform for the identification of caloric restriction mimetics with broad health-improving effects (2020) Autophagy
Caloric Restriction Mimetics against Age-Associated Disease: Targets, Mechanisms, and Therapeutic Potential (2019) Cell Metabolism
Biological Functions of Autophagy Genes: A Disease Perspective (2019)
Yeast as a tool to identify anti-aging compounds (2018) Oxford Journals: FEMS Yeast Research
The flavonoid 4,4′-dimethoxychalcone promotes autophagy-dependent longevity across species (2018) Nature Communications
Therapeutic modulation of autophagy: Which disease comes first? (2019) Cell Death & Differentiation
The Hallmarks of Aging (2013) Cell
The Lysoseeker™ Platform
A unique approach for discovering new autophagy therapeutics.
Rare Monogenic Disease
What if we could offer real hope for serious rare genetic diseases?
Neurodegeneration
What if we could tackle the cause of Alzheimer’s and Parkinson’s Disease?
Our Pipeline
Samsara is leveraging its knowledge of new autophagy biology.
New home and strengthening our scientific team
It’s a busy time for Samsara Therapeutics as we move into our new purpose-built labs and offices in the Wood Centre for Innovation in Oxford.
Autophagy, healthspan and lifespan
Our strategy in Samsara is to treat diseases where there is a high unmet need. But we also want to find out how our molecules work to affect healthspan and longevity.
Introducing Samsara
Over the last twenty years or so, the phenomenon of autophagy has become a hot topic in the world of biology.
© 2021 Samsara Therapeutics | Legal Information | Privacy
© 2021 Samsara Therapeutics
Legal Information | Privacy